RE:EarningsCuraleaf lost 16.5 million dollars last quarter on their 32 million of revenue. Their model of massive dilution and debt will likely move them ahead in revenue over the short term, but this play is massively profitable cant really compare the two as they have a different business approach. Trulieve is growing responsibly, profitability, protecting shareholders value. Curaleaf, and MedMan are achieving their growth at the expense of the shareholder and are loosing a ton every quarter that will end up leading to further dilution down the road just to keep their businesses afloat.
legalgreens wrote: Look at what curaleaf had just achieved, they have projections of 400 million for 2019, I'm sure Trulieve can match that considering they had the head start of being the highest revenue cannabis company out there now. Both companies have a grip on their competitors, will be expanding to multiple states, and have more cash than they can think to spend.